Showing results (51-60 of 326) with videos related to
Sort By:
Pageof 33
Current Neurology and Neuroscience Reports|March 8, 2014
Microenvironmental clues for glioma immunotherapyMichael Platten, Katharina Ochs, Dieter Lemke, et al.Neuro-Oncology|September 16, 2023
NLGN4X TCR transgenic T cells to treat gliomasChristoper Krämer, Michael Kilian, Yu-Chan Chih, et al.Frontiers in Neurology|November 5, 2019
Characterization of Contrast-Enhancing and Non-contrast-enhancing Multiple Sclerosis Lesions Using Susceptibility-Weighted ImagingPhilipp Eisele, Katja Fischer, Kristina Szabo, et al.BMC Emergency Medicine|October 12, 2019
Uncompleted emergency department care and discharge against medical advice in patients with neurological complaints: a chart reviewCarolin Hoyer, Patrick Stein, Angelika Alonso, et al.Journal of Neuropsychology|May 22, 2021
Impaired semantic memory during acute transient global amnesiaVesile Sandikci, Anne Ebert, Carolin Hoyer, et al.Case Reports in Neurology|June 20, 2017
HIV-Associated Cerebellar Dysfunction and Improvement with Aminopyridine Therapy: A Case ReportCarolin Hoyer, Angelika Alonso, Beate Schlotter-Weigel, et al.Structure (London, England : 1993)|June 13, 2017
Structural Basis for Aryl Hydrocarbon Receptor-Mediated Gene ActivationKathrin Wiebke Schulte, Edward Green, Annabel Wilz, et al.Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.Journal for Immunotherapy of Cancer|October 17, 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, et al.Theranostics|November 1, 2023
In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.Pageof 33